Member Login
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (NYSE: BHC)
    3. /

NYSE:BHC (Bausch Health Companies Inc.)

About BHC

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (NYSE: BHC) Latest News

    Investing

    3 Promising Turnaround Stocks to Consider

    | Demetris Afxentiou

    Beaten-up stocks like Bombardier, Inc. (TSX:BBD.B) that have lost significant value over a short period of time can prove to…

    Read more »

    The Motley Fool
    Investing

    Which Is the Better Buy: Home Capital Group Inc. or Valeant Pharmaceuticals Intl Inc.?

    | David Jagielski

    Has Home Capital Group Inc. (TSX:HCG) proven to investors that it's worth the risk?

    Read more »

    win
    Investing

    2 Stocks With Profound Market-Beating Upside

    | Joey Frenette

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are compelling options for investors seeking to crush the markets over the medium to long…

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. Still on Track?

    | Demetris Afxentiou

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to reduce its outstanding debt and tout new products with income potential.

    Read more »

    The Motley Fool
    Investing

    3 Drug and Nutrition Stocks That Belong in Your TFSA

    | Ambrose O'Callaghan

    Stocks such as Jamieson Wellness Inc. (TSX:JWEL) offer the potential for explosive growth going forward.

    Read more »

    The Motley Fool
    Investing

    Can Valeant Pharmaceuticals Intl Inc. Sell its Way to Success?

    | Jacob Donnelly

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYXE:VRX) will see it revenue drop as it sells assets to pay off debt. Can it…

    Read more »

    Investing

    3 Turnaround Stocks, 3 Massive Opportunities

    | Karen Thomas, MSc, CFA

    BlackBerry Ltd. (TSX:BB)(NYSE:BB) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have big upside remaining and good early signs of a comeback.

    Read more »

    The Motley Fool
    Investing

    Has Valeant Pharmaceuticals Intl Inc. Proven it Belongs in Your TFSA?

    | Brad Macintosh

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) could once again be a market-beating stock, but are the risks still too high?

    Read more »

    The Motley Fool
    Investing

    New Incentive Program at Valeant Pharmaceuticals Intl Inc. Signals a New Culture That Investors Can Stand by

    | Karen Thomas, MSc, CFA

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is doing the right things to regain shareholders' trust.

    Read more »

    The Motley Fool
    Investing

    Better Turnaround Stock: Valeant Pharmaceuticals Intl Inc. vs. Home Capital Group Inc.

    | Karen Thomas, MSc, CFA

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has big company-specific risk due to its highly levered balance sheet, but it's attempting to…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Q4 Earnings Review: Hold on Tight

    | Mat Litalien, MBA

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) beat fourth-quarter earnings estimates, but it missed on revenues.

    Read more »

    The Motley Fool
    Dividend Stocks

    Is Valeant Pharmaceuticals Intl Inc. Next up on Warren Buffett’s Shopping List?

    | Jason Phillips

    Last week Warren Buffett made an announcement that shocked the market. Does the world's most famous investor have his sights…

    Read more »